Keywords: serono, net, income, rise, below, consensus, forecasts
Serono's 2001 5.2% net income rise below consensus forecasts
Article | 18 February 2002
Switzerland's Serono has posted net income of $316.7 million for 2001, arise of 5.2%, on sales of $1.25 billion (up 15% in local currencies on ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
